Net income surged 171.9% and adjusted EBITDA rose 18.8% year-over-year, driven by higher revenue, cost efficiencies, and non-recurring gains. Investments and dividends increased sharply, with a focus on universalization and regulatory compliance.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.